Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Clinomics Inc. currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 2 distinct examiners but are concentrated within 1 distinct art unit. BAILEY, STEVEN WILLIAM is the busiest examiner, managing 1 pending office action. This suggests that while the company is working with multiple examiners, its current patent interests are focused within a single administrative unit.
The use of 2 distinct examiners for only 2 pending office actions ensures that each case is being evaluated independently. However, the presence of only 1 distinct art unit means that both examiners are likely following the same internal policies and precedents. This environment allows practitioners to apply successful arguments from one case to the other, provided the technical subject matter is similar. Monitoring the 2 pending office actions within this single art unit can provide valuable insights into the specific examination trends affecting the company's biotechnology portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAILEY, STEVEN WILLIAM | 1 | 31.6% | +15.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18024969 | SYSTEM AND METHOD FOR DETERMING GEMETIC POPULATION COMPOSITION USING HYBRID SPECIFIC REFERENCE GENETIC DATA GENERATION FOR POPULATION, BREED, DISEASE GROUPS, AND SPECIES AND ANALYSIS FOR DETERMINIG GENETIC COMPONENTS | BAILEY, STEVEN WILLIAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18024969 | SYSTEM AND METHOD FOR DETERMING GEMETIC POPULATION COMPOSITION USING HYBRID SPECIFIC REFERENCE GENETIC DATA GENERATION FOR POPULATION, BREED, DISEASE GROUPS, AND SPECIES AND ANALYSIS FOR DETERMINIG GENETIC COMPONENTS | BAILEY, STEVEN WILLIAM | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18024969 | SYSTEM AND METHOD FOR DETERMING GEMETIC POPULATION COMPOSITION USING HYBRID SPECIFIC REFERENCE GENETIC DATA GENERATION FOR POPULATION, BREED, DISEASE GROUPS, AND SPECIES AND ANALYSIS FOR DETERMINIG GENETIC COMPONENTS | BAILEY, STEVEN WILLIAM | — | §101§103§112 | Non-Final OA | — | Pending | May 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial